Home
 
  Email:  
  Password:
  Enter
Forget your password?
 
Eric Zwisler, China Regional Director of Zuellig Pharma
 
 
 
 
 
Thursday, November 20, 2008
Stiff legal battle over Viagra continues, Pfizer wins latest round   Free access
Jiangsu issues regs for drug quality control at medical facilities
Wednesday, November 19, 2008
Fosun ups its stake in Tongjitang, again
Balance of power: China SFDA will open offices in the US   Free access
Hebei Province unions aim to boost innovation among vitamin, antibiotics mfrs
Baidu apologizes for ranking unlicensed pharmas
Topfond Pharma shareholders reduce stakes
Hospital stays getting shorter, according to Chinese Hospital Association
PLA physicians pioneer new bone marrow transplant technique, results promising   Free access
Tuesday, November 18, 2008
Not-so-sweet news: 40 million diabetics in China, says Chinese Diabetes Society
Genesis Pharmaceuticals authorizes USD 2 million stock buyback plan
Neptunus Group shuffles equity of subsidiaries
Nepstar installs credit/utility/phone bill pay terminals to attract customers   Free access
Fujian FDA educates drug wholesalers before granting license
Monday, November 17, 2008
We can rebuild it: Dujiangyan gets RMB 800 million for healthcare reconstruction   Free access
SFDA: Imported medical devices must have Chinese labels
Chongqing to receive RMB 400 million from World Bank to build rural clinics   Free access
Shenzhen Accord clarifies takeover rumors
China Resources consolidates stake in Sanjiu Medical and Pharmaceutical
New management for pain-management: China Aoxing appoints new board   Free access
CAS to explore new methods of creating pluripotent stem cells
Friday, November 14, 2008
Guangzhou Pharmaceutical Holdings to relocate subsidiaries to Panyu Park zone
Top US HHS and FDA officials to visit Beijing, food safety on the menu   Free access
US restricts import of milk-containing products from China
Bayer Healthcare launches development project for hemophilia centers   Free access
 
 
     About us | Contact us | FAQ | Feedback   © GB Group limited. All right reserved.  
pharmaceutical,china pharmaceutical,pharm,pharmhound,generalbiologic,China drug,Drug discovery,Pharmaceutical market,China Antibody,China preclinical,China clinical trial,China CRO,China API,Matthew Chervenak,China research and development,China hepatitis,China cancer,China diabetes,China oncology,China cardiovascular,China CNS,China disease